The efficacy of Penneedleplus for the patients using insulin

The efficacy of Penneedleplus for the patients using insulin - Penneedleplus study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029654

Enrollment

Registered

2017-10-22

Start date

2017-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with diabetes, using insulin

Interventions

The patients using nanopass are randomized to perform crossover study. They use penneedleplus for the first 3 days and penneedle for the second 3 days. The patients using nanopass are randomized t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with diabetes using insulin. 2.Agreemnt with paper.

Exclusion criteria

Exclusion criteria: Inappropriate for the research

Design outcomes

Primary

Measure	Time frame
The level of pain by VAS, after using each needle for 3 days	—

Secondary

Measure	Time frame
The important points for the patients using insulin needle	—

Countries

Japan

Contacts

Public ContactJunko Sato

Juntendo University Shizuoka Hospital Department of Diabetes, Endocrinology and Metabolism

jsato@juntendo.ac.jp055-948-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026